Trial Outcomes & Findings for Exercise Mode and Acute Bone Resorption (NCT NCT04815824)

NCT ID: NCT04815824

Last Updated: 2025-07-20

Results Overview

CTX is a blood marker of bone resorption. Reference range is 0.1-0.8 ng/mL with lower concentrations suggesting less bone resorption.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

9 participants

Primary outcome timeframe

Before to up to 48 hours after acute exercise bout

Results posted on

2025-07-20

Participant Flow

Participant milestones

Participant milestones
Measure
Stationary Cycling First, Then Treadmill Walking
All participants will complete one, 60-minute bout of stationary cycling. Approximately one week later, participants will complete a 60-minute bout of treadmill walking.
Treadmill Walking First, Then Stationary Cycling
All participants will complete one, 60-minute bout of treadmill walking. Approximately one week later, participants will complete a 60-minute bout of stationary cycling.
First Intervention (60 Minutes)
STARTED
5
4
First Intervention (60 Minutes)
COMPLETED
5
4
First Intervention (60 Minutes)
NOT COMPLETED
0
0
Washout (1 Week)
STARTED
5
4
Washout (1 Week)
COMPLETED
5
4
Washout (1 Week)
NOT COMPLETED
0
0
Second Intervention (60 Minutes)
STARTED
5
4
Second Intervention (60 Minutes)
COMPLETED
5
4
Second Intervention (60 Minutes)
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Exercise Mode and Acute Bone Resorption

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Study Participants
n=9 Participants
All participants complete both a stationary cycling and a treadmill walking exercise bout, but the order was randomized.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
Age, Categorical
>=65 years
9 Participants
n=5 Participants
Age, Continuous
72 years
STANDARD_DEVIATION 2 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
8 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
5 Participants
n=5 Participants
Cardiorespiratory Fitness (VO2peak)
25.8 mL/kg/min
STANDARD_DEVIATION 3.5 • n=5 Participants

PRIMARY outcome

Timeframe: Before to up to 48 hours after acute exercise bout

CTX is a blood marker of bone resorption. Reference range is 0.1-0.8 ng/mL with lower concentrations suggesting less bone resorption.

Outcome measures

Outcome measures
Measure
Stationary Cycling
n=9 Participants
All participants will complete one, 60-minute bout of stationary cycling Exercise Mode: Stationary cycling or treadmill walking
Treadmill Walking
n=9 Participants
All participants will complete one, 60-minute bout of treadmill walking Exercise Mode: Stationary cycling or treadmill walking
C-telopeptide of Type I Collagen (CTX) Change
0.09 ng/mL
Standard Error 0.06
0.08 ng/mL
Standard Error 0.07

SECONDARY outcome

Timeframe: Before to up to 48 hours after acute exercise bout

PINP is a blood marker of bone formation. Reference range is 19-80 ng/mL with lower concentrations suggesting less bone formation.

Outcome measures

Outcome measures
Measure
Stationary Cycling
n=9 Participants
All participants will complete one, 60-minute bout of stationary cycling Exercise Mode: Stationary cycling or treadmill walking
Treadmill Walking
n=9 Participants
All participants will complete one, 60-minute bout of treadmill walking Exercise Mode: Stationary cycling or treadmill walking
Procollagen of Type I N-terminal Propeptide (P1NP) Change
-3.1 ng/mL
Standard Error 7.8
-1.5 ng/mL
Standard Error 7.1

Adverse Events

Stationary Cycling

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Treadmill Walking

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Sarah Wherry

VA Eastern Colorado Health Care System

Phone: 303-704-8054

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place